Drugs / V502
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00365443 | Oct 2006 → ? | anogenital human papillomavirus infection, cervical cancer | Merck Sharp & Dohme LLC | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V502 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00365443 ↗ |
| Modality | Vaccine | “investigational vaccine” NCT00365443 ↗ |